File S1 - Gold(I)-Triphenylphosphine Complexes with Hypoxanthine-Derived Ligands: In Vitro Evaluations of Anticancer and Anti-Inflammatory Activities

Supporting Information. The results of elemental analysis, FTIR, 1H and 13C NMR, and ESI–MS experiments for 1–9. Table S1. Crystal data and structure refinements for [Au(L1)(PPh3)] (1) and [Au(L3)(PPh3)] (3). Table S2. Selected bond lengths and angles in complexes 1 and 3. Figure S1. Parts of the crystal structure of complex [Au(L1)(PPh3)] (1). Table S3. Selected non-covalent contacts and their parameters for 1. Figure S2. Parts of the crystal structure of complex [Au(L3)(PPh3)] (3). Table S4. Selected non-covalent contacts and their parameters for 3. Figure S3. TG/DTA curves of the complexes 1 and 4. Figure S4. Effects of the Au(I) complexes, and Auranofin on the LPS-induced degradation of IκB-α. Figure S5. 31P NMR spectrum of complex 6. (DOCX) CCDC Nos. 1010556 and 1010557 contain the supplementary crystallographic data for 1, and 3, respectively. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: [phone]; or email: [e-mail]. (DOCX)